Skip to content
MarketScale
‹ Back to IndustriesHealthcare

The Cost of Waiting: Why Healthcare Can't Afford Slow Decisions with Mark Van Sumeren

On this episode of I Don't Care with Dr. Kevin Stevenson, healthcare strategist Mark Van Sumeren discusses why healthcare organizations often struggle with slow decision-making, citing structural causes like unclear decision authority and misaligned incentives. He and Stevenson advocate for "deliberate speed"—clarifying who owns a decision, what information is needed, and when it must be made—amid tightening margins and rapid change.

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from I Don't Care on MarketScale.

By Kevin Stevenson · Healthcare StrategyDecision-makingOrganizational LeadershipOperational Efficiency
Share

Key takeaways

01

Healthcare organizations often move slowly on decisions due to consensus-driven governance, unclear decision authority, misaligned incentives, and reluctance to accept failure.

02

Van Sumeren describes 'decision pace is capacity' and advocates for 'deliberate speed'—thoughtful decisions made without letting deliberation itself become the obstacle.

03

The conversation highlights opportunities in nonclinical spending and lessons healthcare can learn from industries with greater financial and operational discipline.

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

Healthcare organizations spend enormous amounts of time developing strategies, analyzing opportunities, and discussing transformation. The challenge often comes when it is time to actually make a decision.

On this episode of I Don’t Care with Dr. Kevin Stevenson, Dr. Kevin Stevenson welcomes Mark Van Sumeren, a healthcare strategist whose 45-year career has spanned health systems, consulting, supply chain, publicly traded companies, and private equity-backed organizations. That experience has given Van Sumeren a unique perspective on why healthcare organizations often move more slowly than their counterparts in other industries.

Central to the conversation is Van Sumeren’s observation that “decision pace is capacity.”

The structural reasons for slow decision-making

Stevenson and Van Sumeren explore the structural reasons behind healthcare’s tendency toward “paralysis by analysis,” including consensus-driven governance, unclear decision authority, misaligned incentives, and an organizational reluctance to accept failure. They discuss the need for what Van Sumeren calls deliberate speed—making thoughtful, informed decisions without allowing deliberation itself to become the obstacle.

Learning from other industries

The conversation also examines healthcare supply chain strategy, the significant opportunity surrounding nonclinical spending, and what health systems can learn from industries that operate with greater financial and operational discipline.

The message is not that healthcare should simply move faster. It is that organizations must become better at determining who owns a decision, what information is necessary to make it, and when that decision must be made. In an environment of tightening margins, workforce shortages, and rapid technological change, the cost of waiting continues to grow.

I Don't Care

Part of this channel

I Don't Care

Candid healthcare leadership conversations with Kevin Stevenson

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

Kevin Stevenson
Kevin StevensonTop Hospital Administrator & Healthcare COO, I Don't Care

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Google’s AlphaGenome Atlas puts billions of DNA variants in reach

AlphaGenome Atlas gives researchers predicted molecular effects for possible DNA changes across the human genome, helping teams prioritize variants for experimental follow-up.

  • 01The Atlas covers roughly nine billion possible single-letter DNA substitutions, according to The Verge.
  • 02Predictions can prioritize research questions but do not establish clinical findings.
  • 03The useful implementation pattern is prediction, study-specific evidence, then validation.

Sep 9, 2026

OpenAI put 10,000 AI agents on Navier–Stokes. Healthcare R&D should pay attention

OpenAI put 10,000 AI agents on Navier–Stokes. Healthcare R&D should pay attention

OpenAI says roughly 10,000 AI agents produced a proposed Navier–Stokes solution in 88 hours, followed by Lean verification. For healthcare and life sciences, the immediate signal is a research workflow built around parallel agents, code execution, provenance and formal checking—not a ready-made clinical simulator.

  • 01OpenAI's result is a proposed proof under review, not a new clinical simulation product.
  • 02The near-term B2B signal is a coordinated research stack combining agents, code and formal verification.
  • 03Healthcare buyers should evaluate provenance, reproducibility, security and cost per validated result.

Sep 9, 2026

Get  checked out

Get checked out

Seeking medical evaluation immediately after a vehicle crash, regardless of how you feel, is essential because adrenaline can mask serious injuries for hours or even up to a full day. A same-day medical visit creates a documented paper trail tied to the accident date, which protects against insurance companies disputing injury claims and denying compensation.

  • 01Feeling fine immediately after a vehicle crash may not accurately reflect one's health condition.
  • 02The body's response to stress can delay the onset of injury symptoms.
  • 03Seek medical evaluation after a crash, even if injuries aren't immediately apparent.

Sep 8, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

About the Experts

Kevin Stevenson
Kevin Stevenson

Top Hospital Administrator & Healthcare COO

I Don't Care

Kevin Stevenson hosts 'I Don't Care', a podcast focused on healthcare topics and discussions. He engages with industry leaders to explore and address pressing healthcare issues.

MV
Mark Van Sumeren

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512